InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,229.26
(
0.22%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

waynebio

Send PM Follow Ignore
Followers 1
Posts 47
Boards Moderated 0
Alias Born 09/28/2006

waynebio

Re: DewDiligence post# 2080

Sunday, 12/03/2006 11:05:24 AM

Sunday, December 03, 2006 11:05:24 AM

Post# of 19309
Dew,

I find the discussion of the sharing arrangement with LFB to be a bit vague in the proxy and hope you can help. It talks about developing jointly to share profits then talks about exclusive rights in Europe for LFB
========================================================
Reading the proxy please clarify what it means that LFB gets exclusive European commercial rights. What benifit from Europe sales of rhFVIIa does GTCB expect?

What is GTCB expected to spend to develop rhFVIIa in Europe as part of this agreement, perhaps the production system contribution will not be very expensive?

What help can we expect from LFB when GTCB goes for US FDA approval...sharing of clinical/regulatory info from Europe?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up